Tolerability of Low‐Dose Oral Minoxidil in Patients With Systemic Lupus Erythematosus: A Retrospective Cohort Study

Ähnliche Einträge

• Response to “The Role of Patient‐ and Drug‐Related Factors in Oral Minoxidil and Pericardial Effusion: Analyses of Data From the United States Food and Drug Administration Adverse Event Reporting System”
  von: Devyn Zaminski, et al.
  Veröffentlicht: (2025)
• Response to Calderon‐Casellas et al., “En Coup D'une Veine: Anatomy of a Novel Morphea Mimicker”
  von: Daniel R. Mazori, et al.
  Veröffentlicht: (2025)
• GLP‐1 agonists and hair loss: a call for further investigation
  von: Deesha D. Desai, et al.
  Veröffentlicht: (2024)
• Response to “Systemic correlates of cutaneous manifestations of lupus erythematosus”
  von: Carli Needle, et al.
  Veröffentlicht: (2024)
• Treatment of Short Anagen Syndrome With Low‐Dose Oral Minoxidil
  von: Nolan Francis, et al.
  Veröffentlicht: (2025)